Updated on 28 August 2026
SIGORIA Expertise for Horizon Europe Calls: DISEASE-01, CANCER-02 & TOOL-04
CEO at SIGORIA SECURITY SOLUTIONS
Łódź, Poland
About
EXPERTISE OFFERED FOR THE EXPERTISE OFFERED FOR THE SPECIFIC CALL HORIZON-MISS-2027-02-CANCER-02
• Digital platforms for cancer research and care: SIGORIA offers expertise in building software platforms that support collaboration between research centres, hospitals and clinical teams involved in cancer research and care pathways. • Data integration and AI-supported workflows: We can provide solutions integrating clinical, imaging and research datasets while enabling AI-assisted analysis and diagnostic support. • Patient pathway and research management tools: Our technologies support patient monitoring, workflow optimization and data-driven decision-making across multicentre cancer studies and innovation projects. • Scalable and secure implementation: We ensure secure software development, interoperability and deployment of solutions adapted to both pilot projects and large international consortia.
EXPERTISE OFFERED FOR THE SPECIFIC CALL HORIZON-HLTH-2027-02-DISEASE-01-two-stage • Digital platforms for non-communicable diseases: SIGORIA can develop digital platforms supporting the monitoring of innovative healthcare interventions in non-communicable diseases. • Mobile health applications: We offer expertise in creating mobile applications supporting healthcare monitoring, patient engagement, and data collection. • AI-enabled healthcare solutions: SIGORIA can provide AI modules supporting data analysis and monitoring of innovative healthcare interventions.
EXPERTISE OFFERED FOR THE SPECIFIC CALL HORIZON-HLTH-2027-03-TOOL-04 • Interoperability and data integration: SIGORIA offers expertise in developing solutions supporting interoperability and integration of healthcare data from multiple sources. • Decision-support tools for clinicians: We can develop clinician-facing decision-support layers supporting advanced healthcare applications. • Digital infrastructures for Virtual Human Twin solutions: SIGORIA can contribute through software development and implementation support for data-driven healthcare environments related to Virtual Human Twin solutions
Topic
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Human-Centred Oversight for Trustworthy AI in Health and Cancer Care
- Partner seeks Consortium/Coordinator
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Bram Lievens
Research Valorisation Manager at IMEC-SMIT, Vrije Universiteit Brussel
Brussels, Belgium
Project cooperation
Key Expertise and Contribution Areas
- Partner seeks Consortium/Coordinator
- Consortium/Coordinator seeks Partners
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Leonardo Bertero
EU project manager at INOC - Istituto Nazionale Oncologico Candiolo
Turin, Italy
Project cooperation
Fusing AI/ML with cheminformatics modelling into project concepts
- Partner seeks Consortium/Coordinator
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Evangelia-Mantelena Makri
Project Manager / Biomedical Scientist at Cloudpharm P.C
Athens, Greece